Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

531.85 -0.79 (-0.15%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Thermo Fisher Scientific Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Via Benzinga
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
Is NYSE:TMO suited for quality investing?
Analyzing the Quality Characteristics of THERMO FISHER SCIENTIFIC INC (NYSE:TMO). 
Via Chartmill
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
Via Benzinga
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity
Via Benzinga
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
Looking Into Thermo Fisher Scientific's Recent Short Interest
Via Benzinga
Check Out What Whales Are Doing With TMO
Via Benzinga
Thermo Fisher Scientific to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
$100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. 
Via Investor's Business Daily
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks profits and aims to prevent further unauthorized use of the cells. 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Navigating 5 Analyst Ratings For Thermo Fisher Scientific
Via Benzinga
Decoding Thermo Fisher Scientific's Options Activity: What's the Big Picture?
Via Benzinga
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years
Via Benzinga
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked. 
Via InvestorPlace
3 Stocks With the Most Recent 52-Week Highs
Stocks with 52-week highs could have substantial investment opportunities during the dip in the stock market. 
Via InvestorPlace
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
11 large-cap stocks saw significant gains in the last week, driven by positive earnings and guidance updates. Check if they're in your portfolio. 
Via Benzinga
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
Via Benzinga
3 Nanotechnology Stocks With Microscopic Risk
Explore nanotechnology stocks with potentially low-risk profiles, offering exposure to the expanding industry while maintaining stability. 
Via InvestorPlace
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
Thermo Fisher Scientific (TMO) Q2 2024 Earnings Call Transcript
TMO earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Thermo Fisher Q2 Earnings: Marginal Revenue Dip, Completes Olink Acquisition, Lifts Annual Profit Outlook
Thermo Fisher Scientific's Q2 revenue of $10.54 billion surpassed expectations, with segments showing mixed results. Adjusted EPS rose to $5.37. Recent acquisition of Olink enhances their Life Sciences... 
Via Benzinga
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
Thermo Fisher Scientific Reports Second Quarter 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Nantotech Stocks to Bet On for Market-Crushing Returns
Nanotech stocks lead the way as advancements in nanoparticle analysis and AI integration drive significant growth in this cutting-edge field. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.